Work

Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer

Year: 2013

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2013.09.032

Authors: Andrea R. Hagemann, Akiva P. Novetsky, Israel Zighelboim, Feng Gao, L. Stewart Massad, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Jason D. Wright

Institutions: Washington University in St. Louis, Temple University, Alvin J. Siteman Cancer Center, Columbia University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G2202404319, Washington University Institute of Clinical and Translational Sciences, Cancer Center Support Grant

OpenAlex ID: W2166950437

FWCI: 4.238

Cites: 27

Cited by: 27

Related to: 10